Dihydrofolate Reductase antibody (Cy3)
Quick Overview for Dihydrofolate Reductase antibody (Cy3) (ABIN1418459)
Target
See all Dihydrofolate Reductase (DHFR) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purification
- purified by Protein A
-
Immunogen
- KLH conjugated synthetic peptide derived from human DHFR
-
Isotype
- IgG
-
-
-
-
Comment
-
Excitation / Emission wavelength: 510.550nm / 570.615nm
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 µg/µL
-
Buffer
- Aqueous buffered solution containing 100 µg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4 °C for 12 months
-
Expiry Date
- 12 months
-
-
- Dihydrofolate Reductase (DHFR)
-
Alternative Name
- DHFR
-
Background
- DHFR catalyzes the NADPH-dependent reduction of dihydrofolate to tetrahydrofolate, and is a crucial enzyme for the synthesis of purines, pyrimidines and some amino acids. Inhibition of the activity of this enzyme leads to arrest of DNA synthesis and cell death. Gene expression of methotrexate (MTX)-resistant variants of DHFR in normal hematopoietic cells is a potential strategy to permit administration of larger doses of MTX by alleviating drug toxicity in normal cells and tissues that are drug sensitive.
-
Molecular Weight
- 21kDa
-
Gene ID
- 1719
-
HGNC
- 0
-
Pathways
- Mitotic G1-G1/S Phases
Target
-